Concepedia

Publication | Open Access

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

DOIFull Paper Access

38

Citations

28

References

2018

Year

Steven P. Angus, Janet L. Oblinger, Timothy J. Stuhlmiller, Patrick DeSouza, Roberta L. Beauchamp, Luke Witt, Xin Chen, Justin T. Jordan, Thomas S.K. Gilbert, Anat Stemmer‐Rachamimov,
Neuro-Oncology

Abstract

Co-targeting mTORC1/2 and EPH RTK/SFK pathways could be a novel effective treatment strategy for NF2-deficient meningiomas.

References

YearCitations

Page 1